A clinical pharmacology study of TS-142 in patients with obstructive sleep apnea hypopnea.

Mita Seiji0 个研究点目标入组 40 人开始时间: 2021年2月19日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Subjects must meet all of the following criteria to be included in this study:
•- Japanese male and female, age 20 years or older at the time of informed consent
•- Patients who meet the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria for obstructive sleep apnea hypopnea
•- Other protocol defined inclusion criteria could apply

•Subjects who meet any of the following criteria will be excluded from this study:
•- Patients who meet the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria excepting obstructive sleep apnea hypopnea and insomnia disorder
•- Patients who have clinically significant respiratory dysfunction (bronchiectasis, emphysema, asthma, etc.) other than obstructive sleep apnea hypopnea
•- Patients with percutaneous arterial oxygen saturation (SpO2) <94% by pulse oximetry at visit 1
•- Other protocol defined exclusion criteria could apply

发起方

Mita Seiji